10X Genomics Inc

NASDAQ TXG

Data sourced from iex and EODHD
Download Data

10X Genomics Inc Cash Flow Statement 2018 - 2024

This table shows the Cash Flow Statement for 10X Genomics Inc going from 2018 until 2024. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Net Income
M -60 -49 -93 -62 -51 -17 -42 -64 -42 -18 -17 -11 -12 -416 -66 -40 -21 -7 -10 -11 -4 -76 -15 -6 -11
Depreciation and Amortization
M 11 12 11 12 9 8 8 8 8 7 7 7 6 5 5 4 4 3 2 1 1 1 1 1 1
Non-Cash Items (Other)
M 44 -17 26 0 2 1 1 0 0 0 -42 0 0 306 0 0 0 0 0 0 0 1 0 -3 2
Operating Cash Flow
M -16 26 -25 -12 -4 14 -10 -17 -21 6 -26 3 -4 -130 -56 -30 -3 7 15 4 9 -51 -5 -10 -10
Capital Expenditures
M -3 -3 -15 -25 -5 -40 -37 -27 -28 -28 -20 -15 -39 -22 -1 -7 -8 -7 -14 -13 -9 -3 -1 -2 -2
Net Acquisitions
M - - - - - - - - - - - - - - - - - - - - - - - - -
Other Investing Activities
M - - - - -1 -3 -2 - - - - - -5 - - - - - - 0 0 0 0 - -
Investing Cash Flow
M - - - - -1 -3 -2 - - - - - -5 - - - - - - 0 0 0 0 - -
Repayment/Issuance of Debt (Net)
M - - - - -6 - - - -5 -5 -5 -5 -5 0 0 0 -37 -37 -37 -37 0 0 0 - -
Equity Repurchase (Common, Net)
M - - - 7 2 5 2 6 8 9 7 16 9 - - - 3 415 416 2 0 87 0 - -
Dividends Paid
M - - - - - - - - - - - - - - - - - - - 0 0 0 0 - -
Other Financial Activities
M 2 8 4 7 -6 -16 2 6 2 -31 7 16 4 14 487 8 3 12 16 -1 1 36 0 35 35
Financing Cash Flow
M 2 8 4 7 -6 -16 2 6 2 -31 7 16 4 14 487 8 3 12 16 -1 1 36 0 35 35
Exchange Rate Adjustment
M - - - - - - - - - - - - - - - - - - - 0 0 0 0 - -
Beginning Cash
M 359 312 327 340 227 242 282 320 596 609 649 644 689 834 404 432 476 477 61 71 70 88 93 23 -
Ending Cash
M 356 359 312 331 340 227 242 282 320 596 609 649 644 689 834 404 432 476 477 61 71 70 88 23 23
Stock-Based Compensation
M 36 39 40 46 42 41 34 36 26 27 26 27 16 14 14 14 7 5 4 3 1 1 1 1 1
Issuance/Purchase of Shares
M - - - 7 2 5 2 6 8 9 7 16 9 - - - 3 415 416 2 0 87 0 - -
Capital Stock Change
M - - - - - - - - - 0 - - - - - - - - - - - - - - -
Working Capital
M 458 469 458 485 490 504 503 548 603 637 644 644 625 656 755 329 371 418 426 64 65 74 74 - -
Free Cash Flow
M -19 22 -41 -37 -9 -26 -46 -44 -49 -22 -46 -11 -43 -152 -57 -36 -11 0 1 -9 0 -54 -6 -12 -12

StockViz Staff

September 16, 2024

Any question? Send us an email